•A unique genetic alteration drives the pathogenesis of fibrolamellar carcinoma (DNAJB1-PRKCA fusion) and hepatic haemangioendothelioma (CAMTA1-WWTR1 fusion). This evidence concerns the gene WWTR1 and fibrolamellar hepatocellular carcinoma.